FDA Issues Proposal To Amend The Medical Device Quality System Regulation

The FDA is proposing to modify the requirements of its Good Manufacturing Practices (cGMP) regulations to align them with the requirements of the ISO 13485:2016 standard for medical devices. The proposed amendments will affect the 21 CFR Part 4 regulation of combination products. They are part of the FDA’s efforts to align its regulations with the requirements of the international standard. The FDA aims to align its regulations with the requirements of other regulatory authorities in order to provide faster and more consistent access to safe and effective medical devices.


FDA’s Requirement for Manufacturers

The FDA’s requirement for manufacturers of medical devices to meet the requirements of 21 CFR Part 820 was first established in 1978. In 1997, the FDA added new design controls to the requirements for validating the safety and effectiveness of medical devices. The agency believed that this move would benefit the medical device industry and the public.

ISO 13485

The first version of ISO 13485, which was released in 1996, was focused on the requirements for the implementation of quality management systems for the medical device industry. The second edition, which was released in 2003, focused on the requirements for the regulation of these systems. The third edition, which was released in 2016, added new features and improved the quality management systems’ compliance with the requirements of 21 CFR Part 820.

The FDA is proposing to incorporate the requirements of the International Organization for Quality Management Systems (ISO 13485) in its regulations for medical devices. This would help ensure that the systems are used properly and meet the requirements of the FDA. The agency noted that the requirements of the two regulations are generally in line with each other. After the convergence of the two, the regulations for medical devices would be similar. The agency is also proposing to accept the requirements of the ISO 13485:2016 without modifying them. It will also propose a requirement that would replace the existing requirement.

The FDA is not proposing to modify the requirements of 21 CFR Part 820 for establishments that manufacture finished devices. However, the agency noted that the legal authority to require these requirements exists for certain entities. The agency noted that the proposed amendments would only address the extent of the conflicts between the conflicting regulations.

The finished device is any component or accessory that can function seamlessly on its own regardless of its packaging or labeling. A manufacturer is anyone who designs, manufactures, or processes a finished device. Nonconformity is a term that refers to the failure of a manufacturing process or component to meet a certain requirement.

Remanufacturers are those who modify or repackage a finished product to meet a specific requirement or improve its safety or performance. Rework is a process that involves taking a non-conforming product and performing a series of actions to ensure that it meets the requirements of the DMR. The validation process is a process that aims to establish that a manufacturing process consistently produces a finished product that meets its predetermined specifications.

Read more: https://www.complianceg.com/fda-proposal-to-medical-device-quality-system-regulations/

Comments

Post a Comment

Popular posts from this blog

Common Medical Device Regulatory Compliance Problems

With the emerging technologies, medical devices are a cost factor despite their long-term cost-saving modes and improved patient safety measures. However, medical device manufacturing companies should take precautions to avoid compliance regulations issues.. Let’s look at the most common  medical device regulatory compliance  problems faced by quality leaders in the 21st century. Read More .
Read more

Document Control vs. Document Management: A Comprehensive Comparison

Image
This article gives you a clear view about the distinctions between Document Control and Document Managementsystems within the context of organizational processes. Document Control focuses on the regulation and management of critical documents, ensuring compliance, version control, and traceability. In contrast, Document Management encompasses a broader approach, encompassing document creation, storage, retrieval, collaboration, and workflow management. The abstract delves into the significance of both systems, their respective features, benefits, and how they contribute to enhancing overall efficiency, productivity, and data integrity in diverse industries. By understanding the unique roles of Document Control and Document Management, organizations can make informed decisions in selecting the most suitable system to meet their specific needs and compliance requirements. document-control-vs-document-management Source: Document Management (vs) Document Control (complianceg.com)  
Read more

What Makes for a Great Validation Lead

  If you need a warm body for a  Validation  project, call the other guy, but if you need proficient, trained, critical-thinking resources, contact us.    Compliance Group carefully vets our resources. New employees are placed with veteran employees to shadow and learn from them. We routinely train our resources on Computer Software Assurance (CSA), Data Integrity, MS Word skills, trends in  Validation,  and regulatory enforcement activities.   Read More .
Read more